1-5 of 5
Gunther Gastl, Prof., Dr.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Indoleamine 2,3-Dioxygenase (IDO1) Levels and Activity Are Increased in Early Chronic Phase Chronic Myelogenous Leukemia (CML-CP) and Correlate with Molecular Response to Nilotinib Therapy

Sieghart Sopper, PhD, Satu Mustjoki, MD PhD, Gunther Gastl, Prof., Dr., Zlatko Trajanoski, Prof. Dr., Frank Giles, MD MB, Andreas Hochhaus, MD, Simon Geisler, Dietmar Fuchs, Prof. Dr., Dominik Wolf, MD, Jeroen J.W.M. Janssen, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1912.
https://doi.org/10.1182/blood.V128.22.1912.1912
Published: 2016
Journal Articles

In-Vitro Actvity of Pixantrone (PIX) in Plasma Cell Leukaemia (PCL) and Early Clinical Activity in a Pixantrone–Pomalidomide–Dexamethasone (PiPoD) Combination

Ella Willenbacher, MD, Wolfgang Willenbacher, MD, Gunther Gastl, Prof., Dr., Irmgard Verdorfer, MDPhD, Brigitte Kircher, PhD
Journal: Blood
Blood (2014) 124 (21): 5732.
https://doi.org/10.1182/blood.V124.21.5732.5732
Published: 2014
Journal Articles

Reduced Expression of CD62L Is Associated with Increased ADAM17 Activity and Predicts Molecular Response to Nilotinib Therapy in Patients with Early Chronic Phase Chronic Myelogenous Leukemia (CML-CP)

Sieghart Sopper, PhD, Satu Mustjoki, MD PhD, Angelica Loskog, PhD, Bjorn T. Gjertsen, MD PhD, Ute Mark, Jens Haenig, Nidas Jurjonas, Gunther Gastl, Prof., Dr., Frank Giles, MDMB, Andreas Hochhaus, MD, Gert J Ossenkoppele, MD PhD, Kimmo Porkka, MD PhD, Dominik Wolf, MD
Journal: Blood
Blood (2014) 124 (21): 4522.
https://doi.org/10.1182/blood.V124.21.4522.4522
Published: 2014
Journal Articles

Immune Monitoring In Patients With Early Chronic Phase Chronic Myelogenous Leukemia (CML-CP) Treated With Frontline Nilotinib

Sieghart Sopper, PhD, Satu Mustjoki, MD, PhD, Angelica Loskog, PhD, Bjorn T Gjertsen, MD PhD, Richard Greil, MD, Alois Lang, MD, Werner Linkesch, MD, Josef Thaler, MD, Tobias Gedde-Dahl, III, MD, PhD, Henrik Hjorth-Jansen, MD, Waleed Majeed, MD, Kourosh Lofti, MD, PhD, Johan Richter, MD, PhD, Sören Lehman, MD, Leif Stenke, MD, PhD, Ulla Olsson-Strömberg, MD, PhD, Jesper Stentoft, MD, Ward Posthuma, MD, PhD, Willem Smit, Edo Vellenga, MD, PhD, Gregor Verhoef, Augustin Ferrant, MD, PhD, Jan Van Droogenbroeck, MD, Ute Mark, Jens Haenig, Nidas Jurjonas, Gunther Gastl, Prof., Dr., Frank Giles, MD MB, Andreas Hochhaus, MD, Gert J. Ossenkoppele, MD PhD, Kimmo Porkka, MD, PhD, Dominik Wolf, MD
Journal: Blood
Blood (2013) 122 (21): 2731.
https://doi.org/10.1182/blood.V122.21.2731.2731
Published: 2013
Journal Articles

GRP-78 Secreted by Tumor Cells Blocks the Anti-Angiogenic Activity of Bortezomib.

Johann Kern, Gerold Untergasser, PhD, Christoph Zenzmaier, Bettina Sarg, Gunther Gastl, Prof., Dr., Eberhard Gunsilius, M.D., Michael Steurer, MD
Journal: Blood
Blood (2009) 114 (22): 4805.
https://doi.org/10.1182/blood.V114.22.4805.4805
Published: 2009